Infectious Diseases News and Research

RSS

How long can cognitive impairment persist after hospitalization due to COVID-19?

In a new study, researchers examined the aspects of cognitive impairment after hospitalization due to coronavirus disease 2019 (COVID-19).

1 Aug 2022

New instrument can be clipped on to a smartphone to rapidly test for Zika virus in blood

As seen with the COVID-19 pandemic, detection methods that are rapid, simple, accurate, and sensitive are vital for detecting viral pathogens and for controlling the spread of infectious diseases.

31 Jul 2022

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

The International Vaccine Institute (IVI) successfully completed the '2022 Introductory Course for Biologics Development and Manufacturing' on July 29 to train 106 participants from 24 low- and middle-income countries (LMICs) and 32 from the Republic of Korea.

29 Jul 2022

Using a bibliometric approach to evaluate the scientific literature on digital teaching in medical education

JMIR Publications recently published "Digital Teaching in Medical Education: Scientific Literature Landscape Review" in JMIR Medical Education which reported that digital teaching in medical education has grown in popularity in recent years.

29 Jul 2022

Study finds asymptomatic SARS-CoV-2 infection induced comparable memory B cell responses to mild symptomatic infection in young adults

Researchers identified that among healthy young adults, the development of SARS-CoV-2 triggered memory B cell and antibody reactions were equivalent following mildly symptomatic or asymptomatic infections.

29 Jul 2022

One Health approach for emergent and resurgent infectious diseases

A recent editorial published in The Lancet Microbe underscored the ‘One Health’ policy for surveilling emergent infectious diseases.

29 Jul 2022

New breakthrough shows antimicrobial resistance is more evolved than previously recognized

Researchers have discovered a significant and previously unknown mechanism that many bacteria use to resist antibiotics.

29 Jul 2022

Moderna COVID vaccine is more effective in older and sicker veterans over time

Researchers report the higher effectiveness of the Moderna COVID-19 vaccine as compared to the Pfizer COVID-19 vaccine.

28 Jul 2022

Everything you need to know about Paxlovid — especially, should you take it?

When President Joe Biden tested positive for covid-19 on July 21, his physician recommended he take the antiviral drug Paxlovid.

28 Jul 2022

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

In our latest interview, News-Medical speaks to Simon Parker, an infectious disease specialist, about hepatitis C diagnostics and testing, as well as why the global fight against hepatitis cannot wait.

28 Jul 2022

The kinetics of SARS-CoV-2 nucleocapsid antibodies up to 21 months after infection

Researchers found significant seroreversion of total anti-nucleocapsid immunoglobulin.

28 Jul 2022

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger immune response, and suggesting a dose up the nose has an advantage over a shot.

27 Jul 2022

Innovative technology reveals new insights into cellular reservoirs of HIV

In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of cutting-edge technology revealed new insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research. NIAID is part of the National Institutes of Health.

27 Jul 2022

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

The intranasal delivery of amph-protein vaccines is a potential approach to elicit a mucosal immune response against many infectious diseases.

26 Jul 2022

Researchers pinpoint multiple zoonotic origins of SARS-CoV-2

In a pair of related studies, published July 26, 2022 online via First Release in Science, researchers at University of California San Diego, with colleagues on four continents, show that the origin of the COVID-19 pandemic in 2019 was at the Huanan Seafood Wholesale Market in Wuhan, China, and resulted from at least two instances of the SARS-CoV-2 virus jumping from live animal hosts to humans working or shopping there.

26 Jul 2022

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

Researchers at Saint Louis University's School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that formerly could only be treated with a liver transplant.

26 Jul 2022

Infectious Diseases News and Research

How long can cognitive impairment persist after hospitalization due to COVID-19?

New instrument can be clipped on to a smartphone to rapidly test for Zika virus in blood

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

Using a bibliometric approach to evaluate the scientific literature on digital teaching in medical education

Study finds asymptomatic SARS-CoV-2 infection induced comparable memory B cell responses to mild symptomatic infection in young adults

One Health approach for emergent and resurgent infectious diseases

New breakthrough shows antimicrobial resistance is more evolved than previously recognized

Moderna COVID vaccine is more effective in older and sicker veterans over time

Everything you need to know about Paxlovid — especially, should you take it?

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

The kinetics of SARS-CoV-2 nucleocapsid antibodies up to 21 months after infection

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

Innovative technology reveals new insights into cellular reservoirs of HIV

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

Researchers pinpoint multiple zoonotic origins of SARS-CoV-2

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

New method uses drones to quickly deliver at-home COVID-19 diagnostic tests

Researchers investigate a drug used for neuromuscular weakness as potential treatment for botulism

Using CRISPR technology to successfully prevent and treat SARS-CoV-2 infections

New RT-PCR platform gives results faster than other COVID-19 tests on the market

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News